跳至主要内容
临床试验/NCT04568837
NCT04568837尚未招募4 期

Postoperative Steroids and Recovery After Spine Fusion

Oregon Health and Science University1 个研究点 分布在 1 个国家目标入组 420 人开始时间: 2025年3月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
尚未招募
入组人数
420
试验地点
1
主要终点
Morphine equivalent pain medication use over the length of hospitalization

研究概览

简要总结

This trial studies how well low-dose postoperative corticosteroids (FDA approved) affect patient outcomes (patient reported outcomes, pain medication use, length of stay, major complications, and time to first bowel movement) after thoracic and/or lumbar spine fusion surgery.

详细描述

PRIMARY OBJECTIVES This study aims to compare patient outcomes (patient reported outcomes, pain medication use, length of stay, major complications, and time to first bowel movement) between subjects that receive either 20 mg of PO prednisone or 1 mL of 4 mg/mL of IV dexamethasone sodium phosphate and a control group.

OUTLINE Participants are patients who elect to participate in the study prior to scheduled thoracic and/or lumbar spine fusion surgery at Oregon Health and Science University. Participants undergo their scheduled spine fusion surgery. After surgery, participants are randomized into either the study drug group or the control (non-treatment) group. If randomized into the study drug group, participants will orally take a daily dose of 20 mg of prednisone (1 mL of 4 mg/mL dexamethasone sodium phosphate if unable to tolerate oral administration) on postoperative days one and two.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
50 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • All patients over the age of 50 undergoing thoracic and/or lumbar fusion with a Spine Center surgeon will be included

排除标准

  • Patient is already taking chronic steroids
  • Patient is pregnant
  • Patient is decisionally impaired
  • Patient is a prisoner

研究组 & 干预措施

Corticosteroid

Experimental

Participants in this group will receive a daily dose of corticosteroids on postoperative day one and two after spine fusion surgery

干预措施: Prednisone 20 Mg (Drug)

结局指标

主要结局

Morphine equivalent pain medication use over the length of hospitalization

时间窗: From postoperative admission to discharge, up to 4 weeks

This will be measured by converting the dosage of the pain medication administered to its equivalent dosage of morphine.

Number of major complications reported during hospital stay after surgery

时间窗: From postoperative admission to discharge, up to 4 weeks

This will be measured in the total number of major complications (any) that occur during the hospital stay after surgery. These include, infection, neurological deficit, myocardial infarction, stroke, pneumonia, pulmonary embolism, and bleeding.

Length of hospital stay after surgery

时间窗: From postoperative admission to discharge, up to 4 weeks

This will be measured by taking the total minutes the patient stays in the hospital after surgery from time of admission to time of discharge.

Time to first bowel movement in hospital after surgery

时间窗: From postoperative admission to discharge, up to 4 weeks

This will be measured in the total number of minutes from admission after surgery that it takes for the patient to have their first bowel movement recorded.

Morphine equivalent pain medication use over the first 48 hours of hospitalization

时间窗: From postoperative admission to 48 hours after

This will be measured by converting the dosage of the pain medication administered to its equivalent dosage of morphine.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Jung Yoo

Principal Investigator

Oregon Health and Science University

研究点 (1)

Loading locations...

相似试验

Steroids After Spine Fusion Surgery | 临床试验